Sangamo Biosciences reported $340.06M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Alnylam Pharmaceuticals ALNY:US $ 2589.68M 218.9M
Amgen AMGN:US $ 18520M 865M
Avrobio Inc AVRO:US 170.92M 28.22M
Bayer BAYN:GR 38.25B 5.67B
Biocryst Pharmaceuticals BCRX:US $ 511.71M 54.42M
Biogen BIIB:US $ 7915.9M 59.4M
Biomarin Pharmaceutical BMRN:US $ 2394.02M 119.64M
Bluebird Bio BLUE:US $ 254.92M 81.6M
Gilead Sciences GILD:US $ 12629M 2143M
GlaxoSmithKline GSK:LN 28.99B 10.31B
Intercept Pharmaceuticals ICPT:US $ 477.35M 24.94M
IONIS PHARMACEUT IONS:US $ 2253.12M 91.92M
Johnson & Johnson JNJ:US $ 60424M 555M
Karyopharm Therapeutics KPTI:US $ 276.53M 927K
Merk MRK:US $ 31184M 918M
Novartis NOVN:VX 37.24B 8.48B
Omeros OMER:US $ 210.22M 37.67M
Pfizer PFE:US $ 54420M 5273M
Regulus Therapeutics RGLS:US $ 57.93M 7.3M
Sangamo Biosciences SGMO:US $ 340.06M 58.7M
Sarepta Therapeutics SRPT:US $ 2530.95M 73.15M
Ultragenyx Pharmaceutical RARE:US $ 707.52M 149.08M
Vertex Pharmaceuticals VRTX:US $ 10361.3M 800.7M
Ziopharm Oncology ZIOP:US $ 69.77M 9.06M